Visalytics
Visalytics
approved EB-2 (NIW)

Research Lab Specialist Inter

Pharmaceutical Analysis · China · 2025-02-20

Processing Time
469 days
Decision Date
2025-02-20
Location
Michigan
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance analytical techniques crucial for monitoring pharmaceutical quality across drug discovery, manufacturing, and clinical evaluation stages. Her work focuses on developing and optimizing analytical methods to ensure the safety, consistency, and potency of treatments for cancer and chronic conditions. This endeavor aims to improve medication validation processes and enhance the reliability of drug quality assurance.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor contributes to public well-being through improved cancer treatments and supports the economic strength of the U.S. pharmaceutical industry.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 29 publications, 656 citations, and 30+ peer reviews demonstrate her expertise and leadership in pharmaceutical analysis.

3 Waiver Benefit Met

On balance, the petitioner's unique analytical methodologies and their impact on drug safety justify waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 29 peer-reviewed journal articles and 656 citations, demonstrating significant influence in her field. She also provided evidence of over 30 peer reviews, confirming her status as an expert voice in pharmaceutical science. The case successfully satisfied all three Dhanasar prongs by aligning with national health priorities and supporting the economic strength of the U.S. pharmaceutical sector.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Chemist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
New Jersey 47 days 2025-07-30
The petitioner proposes to apply pharmaceutical science methodologies to streamline drug development and ensure regulatory compliance. Her work focuses on formulation development, analytical validation, and regulatory strategy improvement to reduce the time and cost of bringing drug compounds from the lab to the market.
View Case

Others

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
New Jersey 162 days 2025-08-18
The petitioner proposes to develop advanced analytical methods to identify pharmaceutical ingredient impurities in packaging and medical devices. This work focuses on early detection of harmful contaminants to ensure the safety and effectiveness of drugs and medical products.
View Case

Others

Pharmaceuticals · Iran

WeGreened EB-2 (NIW) approved
598 days 2025-09-08
The petitioner proposes to advance drug discovery by designing and improving in-vitro testing methodologies to enhance precision and streamline timelines in pre-clinical research. Her work focuses on creating standardized approaches for toxin assessment to reduce the reliance on animal testing and lower the high failure rates of clinical trials.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 469 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist